Haloperidol
Who holds supplier records for Haloperidol? 8 organisations hold a current record for Haloperidol: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Germany (1), Italy (1), Netherlands (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Haloperidol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/haloperidol
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Haloperidol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 14226 · latest filing Jun 1999
- Mankind Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 34190 · latest filing Nov 2019
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 33692 · latest filing Mar 2019
- VAMSI LABS LTDIndiaCEP Company GMP cert on recordActive DMF 34283 · latest filing Nov 2019
- OLON SPAItaly Company GMP cert on recordActive DMF 24585 · latest filing Jan 2011
- TAPI NL BVNetherlandsActive DMF 4991 · latest filing May 1983
- Janssen Pharmaceutica NVBelgiumCEP Company GMP cert on recordInactive DMF 10946 · latest filing Jun 1994
- Rpg Life Sciences Ltd.IndiaCEP Company GMP cert on recordInactive DMF 23311 · latest filing Nov 2009
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Haloperidol, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MANKIND PHARMA LIMITED New Delhi | IN | CEP 2020-026 - Rev 04 Haloperidol | Oct 2026 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Medak | IN | CEP 2020-360 - Rev 01 Haloperidol, Micronised, non-micronised | Jul 2026 | Inspected Oct 2025 Slovakia |
| VAMSI LABS LIMITED Solapur | IN | CEP 2020-149 - Rev 01 Haloperidol | Jun 2025 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2005-066 - Rev 05 Haloperidol | Dec 2024 | Inspected Apr 2026 Germany |
| RPG Life Sciences Limited Navi Mumbai | IN | R1-CEP 2003-206 - Rev 03 Haloperidol | Jul 2019 | — |
| JANSSEN PHARMACEUTICA NV Beerse | BE | R1-CEP 1998-076 - Rev 09 Haloperidol | Jun 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Haloperidol are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- HEUMANN PCS GMBHInactive DMF 7486 · filed May 1988
- United States · Inactive DMF 7157 · filed Sept 1987
- IMHAUSEN CHEMIE GMBHInactive DMF 6800 · filed Feb 1987
- ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactive DMF 6200 · filed Feb 1986
- A NATTERMANN AND CIE GMBHInactive DMF 5364 · filed Apr 1984
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Haloperidol is an antipsychotic medication used to treat schizophrenia and to control motor and speech tics in people with Tourette's syndrome. It works by altering the effects of chemicals in the brain.
Chemical identity
- IUPAC name
- 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
- Canonical SMILES
- C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
- InChIKey
- LNEPOXFFQSENCJ-UHFFFAOYSA-N
- Synonyms
- Haldol API, haloperidol, Serenace, Aloperidin, Eukystol, Serenase, Serenelfi, Linton, Brotopon, Dozic, Einalon S, Aloperidolo
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Typical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Haloperidol?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Haloperidol: EXCELLA GMBH AND CO KG (Germany), Mankind Pharma Limited (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), VAMSI LABS LTD (India), OLON SPA (Italy), TAPI NL BV (Netherlands), Janssen Pharmaceutica NV (Belgium) and Rpg Life Sciences Ltd. (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Haloperidol Drug Master Files are active?
EXCELLA GMBH AND CO KG (DMF 14226), Mankind Pharma Limited (DMF 34190), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33692), VAMSI LABS LTD (DMF 34283), OLON SPA (DMF 24585) and TAPI NL BV (DMF 4991). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Haloperidol records mean?
5 organisations have only inactive Type II DMFs for Haloperidol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Haloperidol have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Haloperidol on the EDQM register, including MANKIND PHARMA LIMITED New Delhi (IN), MSN LIFE SCIENCES PRIVATE LIMITED Medak (IN), VAMSI LABS LIMITED Solapur (IN), EXCELLA GMBH & CO. KG Feucht (DE), RPG Life Sciences Limited Navi Mumbai (IN) and JANSSEN PHARMACEUTICA NV Beerse (BE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Haloperidol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Haloperidol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.